The mission of the Newborn Screening Translational Research Network (NBSTRN) was to
facilitate newborn screening research to discover novel technologies, treatments, and
interventions through the development of resources, tools, and expertise. The NBSTRN
was a key component of the Eunice Kennedy Shriver National Institute of Child Health
and Human Development (NICHD) Hunter Kelly Newborn Screening Research Program.
The American College of Medical Genetics and Genomics (ACMG) operated the NBSTRN
through a contract from NICHD.
This project was funded in whole with Federal funds from the NICHD, National Institutes
of Health, Department of Health and Human Services, under Contract No.
HHSN275201800005C.
Funding for this program concluded in March 2024, marking the program’s completion.